Clinical Trial: Safety and Efficacy of a Prebiotic Blend in Healthy Humans

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07514741) titled 'Safety and Efficacy of a Prebiotic Blend in Healthy Humans' on Feb. 04.

Brief Summary: The GRASP Trial is a 30-day, randomized, double-blind, placebo-controlled study (Protocol No.: GW-2025-02) designed to evaluate the safety and tolerability of a novel multi-fiber prebiotic blend in healthy adult volunteers (age 18-60, normal BMI). Participants will be randomized (1:1:1) to receive either a low dose (1 dose/day), a high dose (2 doses/day), or an identical placebo powder for 30 days. The primary objective is to evaluate safety and tolerability, measured by the incidence and severity of gastrointestinal adverse events (AEs) and disco...